JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB179477

Anti-p53 antibody [EPR17343]

  • RabMAb
  • Recombinant
  • KO Validated
  • Lab Essentials
  • 20ul selling size
  • What is this?

3

(2 Reviews)

|

(46 Publications)

Rabbit Recombinant Monoclonal P53 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 46 publications.

View Alternative Names

P53, TP53, Cellular tumor antigen p53, Antigen NY-CO-13, Phosphoprotein p53, Tumor suppressor p53

7 Images
Immunocytochemistry/ Immunofluorescence - Anti-p53 antibody [EPR17343] (AB179477)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-p53 antibody [EPR17343] (AB179477)

ab179477 staining p53 in wild-type HAP1 cells (top panel) and p53 knockout HAP1 cells (bottom panel). The cells were fixed with methanol (5min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab179477 at 1/500 dilution and ab195889 at 1/250 dilution (shown in pseudo colour red) overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to Rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green). Nuclear DNA was labelled in blue with DAPI.

Western blot - Anti-p53 antibody [EPR17343] (AB179477)
  • WB

Supplier Data

Western blot - Anti-p53 antibody [EPR17343] (AB179477)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

Negative control : HL-60 (p53 null), NCI-H1299 (p53 null).

The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 21941372, PMID : 21779513, PMID : 25996291).

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

In Western blot, Anti-p53 antibody [DO-1] - ChIP Grade (ab1101) staining at 1/1000 dilution.

In Western blot, Anti-p53 antibody [EPR17343] (ab179477) staining at 1/1000 dilution.

All lanes:

Western blot - Anti-TP53 (phospho S376+S377+S392) antibody [RM1161] (<a href='/en-us/products/primary-antibodies/tp53-phospho-s376s377s392-antibody-rm1161-ab322465'>ab322465</a>) at 1/1000 dilution

Lane 1:

Untreated HCT 116 (human colorectal carcinoma epithelial cell) whole cell lysate at 20 µg

Lane 2:

HCT 116 treated with 20uM etoposide for 15 hours whole cell lysate at 20 µg

Lane 3:

Untreated A549 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg

Lane 4:

A549 treated with 500nM doxorubicin for 24 hours whole cell lysate at 20 µg

Lane 5:

A431 (human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg

Lane 6:

HL-60 (human acute promyelocytic leukemia promyeloblast) whole cell lysate at 20 µg

Lane 7:

NCI-H1299 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Observed band size: 53 kDa,26-48 kDa,36 kDa

false

Exposure time: 10s

Western blot - Anti-p53 antibody [EPR17343] (AB179477)
  • WB

Supplier Data

Western blot - Anti-p53 antibody [EPR17343] (AB179477)

Blocking/dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-p53 antibody [EPR17343] (ab179477) at 1/20000 dilution

All lanes:

T-47D (Human ductal breast epithelial carcinoma cell line) whole cell lysates at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution

Predicted band size: 43 kDa

Observed band size: 44 kDa,53 kDa

false

Western blot - Anti-p53 antibody [EPR17343] (AB179477)
  • WB

Lab

Western blot - Anti-p53 antibody [EPR17343] (AB179477)

Western blot : Anti-p53 antibody [EPR17343] ab179477 staining at 1/2000 dilution, shown in green; Mouse anti-CANX ab238078 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 50 kDa in Wild-type MCF7 cell lysates with no signal observed at this size in TP53 knockout MCF7 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5pc Milk in TBS-0.1 % Tween 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-p53 antibody [EPR17343] (ab179477) at 1/2000 dilution

Lane 1:

Wild-type MCF7 whole cell lysate at 20 µg

Lane 2:

Western blot - Human TP53 knockout MCF7 cell line (<a href='/en-us/products/cell-lines/human-tp53-knockout-mcf7-cell-line-ab286440'>ab286440</a>) at 20 µg

Lane 3:

Wild-type A549 whole cell lysate at 20 µg

Lane 4:

TP53 knockout A549 whole cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution

Predicted band size: 50 kDa

Observed band size: 50 kDa

false

Western blot - Anti-p53 antibody [EPR17343] (AB179477)
  • WB

Supplier Data

Western blot - Anti-p53 antibody [EPR17343] (AB179477)

Blocking and Diluting buffer and concentration : 5% NFDM/TBST.

Saos-2, PC-3 and HL-60 cells are p53 null cell lines.

All lanes:

Western blot - Anti-p53 antibody [EPR17343] (ab179477) at 1/2000 dilution

Lane 1:

HEK-293 (Human epithelial cells from embryonic kidney) whole cell lysates at 20 µg

Lane 2:

A431 (Human epidermoid carcinoma) whole cell lysates at 20 µg

Lane 3:

Saos-2 (Human osteosarcoma cell line) whole cell lysates at 20 µg

Lane 4:

HL-60 (Human promyelocytic leukemia cells) whole cell lysates at 20 µg

Lane 5:

PC-3 (Human prostate adenocarcinoma cell line) whole cell lysates at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution

Predicted band size: 43 kDa

Observed band size: 44 kDa

false

Western blot - Anti-p53 antibody [EPR17343] (AB179477)
  • WB

Lab

Western blot - Anti-p53 antibody [EPR17343] (AB179477)

Lane 1 : Wild-type HAP1 cell lysate (20 μg)

Lane 2 : p53 knockout HAP1 cell lysate (20 μg)

Lane 3 : A431 cell lysate (20 μg)

Lane 4 : Saos-2 cell lysate (20 μg)

Lanes 1 - 4 : Merged signal (red and green). Green - ab179477 observed at 53 kDa. Red - loading control, ab8226, observed at 42 kDa.

ab179477 was shown to specifically react with p53 in wild type HAP1 cells along with additional cross reactive bands. No band was observed with p53 knockout samples were used.

Wild-type and p53 knockout samples were subjected to SDS-PAGE. ab179477 and ab8226 (loading control to beta Actin) were diluted to 1/2000 and 1/1000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-p53 antibody [EPR17343] (ab179477)

Predicted band size: 43 kDa

false

Western blot - Anti-p53 antibody [EPR17343] (AB179477)
  • WB

Lab

Western blot - Anti-p53 antibody [EPR17343] (AB179477)

All lanes:

Western blot - Anti-p53 antibody [EPR17343] (ab179477) at 1/2000 dilution

Lane 1:

Untreated HCT 116 (Human colorectal carcinoma) whole cell lysate

Lane 2:

HCT 116 (Human colorectal carcinoma) whole cell lysate with 0.5μM Doxorubicin for 24hours whole cell lysate

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 43 kDa

Observed band size: 53 kDa

false

  • Carrier free

    Anti-p53 antibody [EPR17343] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR17343

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

Based on the results of the knockout validation testing this antibody may not be suitable for IHC-P, Flow Cyt, IP or ChIP. Please contact our Scientific Support team for additional information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The protein p53 also known as TP53 or tumor protein p53 has a molecular weight of approximately 53 kDa. It acts as a transcription factor and plays a major role in cell cycle regulation apoptosis and maintaining genomic stability. This protein mainly expresses in the nucleus of cells and acts as a critical regulator of cellular responses to stress signals including DNA damage. Scientists commonly use p53 antibodies in various assays like western blot and p53 immunofluorescence to detect and study its expression and functional status in cells.
Biological function summary

P53 functions to control cell division and apoptosis serving as a guardian of the genome by preventing mutation accumulation. It does not form part of a larger complex under normal conditions but interacts with various other molecules to execute its functions. p53 can activate or suppress the transcription of numerous genes involved in cell cycle arrest DNA repair and programmed cell death allowing it to halt the progression of damaged cells and trigger repair mechanisms or eliminate those that cannot be repaired.

Pathways

P53 acts within several key biological pathways such as the p53 signaling pathway and the intrinsic apoptotic pathway. Its activity involves interaction with proteins like MDM2 which regulates p53 through ubiquitin-mediated degradation and ATM kinase which phosphorylates p53 in response to DNA damage. These interactions ensure appropriate cellular responses during stress and are vital for maintaining homeostasis.

P53 mutation or inactivation is often associated with the development of cancer given its role in controlling cell division and preventing tumor formation. Specifically its dysfunction has been linked to cancers such as breast cancer and lung cancer. Additionally p53 can interact with other mutant proteins like Ras compounding mutations that contribute to tumor progression and aggressive cancer phenotypes. Understanding these interactions and the status of p53 can be important in developing targeted cancer therapies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed : 11025664, PubMed : 12524540, PubMed : 12810724, PubMed : 15186775, PubMed : 15340061, PubMed : 17317671, PubMed : 17349958, PubMed : 19556538, PubMed : 20673990, PubMed : 20959462, PubMed : 22726440, PubMed : 24051492, PubMed : 24652652, PubMed : 35618207, PubMed : 36634798, PubMed : 38653238, PubMed : 9840937). Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type (PubMed : 11025664, PubMed : 12524540, PubMed : 12810724, PubMed : 15186775, PubMed : 15340061, PubMed : 17189187, PubMed : 17317671, PubMed : 17349958, PubMed : 19556538, PubMed : 20673990, PubMed : 20959462, PubMed : 22726440, PubMed : 24051492, PubMed : 24652652, PubMed : 38653238, PubMed : 9840937). Negatively regulates cell division by controlling expression of a set of genes required for this process (PubMed : 11025664, PubMed : 12524540, PubMed : 12810724, PubMed : 15186775, PubMed : 15340061, PubMed : 17317671, PubMed : 17349958, PubMed : 19556538, PubMed : 20673990, PubMed : 20959462, PubMed : 22726440, PubMed : 24051492, PubMed : 24652652, PubMed : 9840937). One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression (PubMed : 12524540, PubMed : 17189187). Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (PubMed : 12524540). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (PubMed : 12524540). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 (PubMed : 24051492).
See full target information TP53

Publications (46)

Recent publications for all applications. Explore the full list and refine your search

Biomolecules & therapeutics 33:365-377 PubMed39989046

2025

Artesunate Inhibits the Proliferation and Migration of Cutaneous Squamous Cell Carcinoma by Regulating the SLC7A11-GPX4 Pathway via the p300-p53 Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Xinyan Huang,Wenxi Wang,Songzhao Zhang,Lili Li,Jihui Huang

Clinical and experimental pharmacology & physiology 52:e70022 PubMed39788129

2025

Diclofenac Enhances the Response of BRAF Inhibitor to Melanoma Through ROS/p38/p53 Signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Haihong Qin,Zheng Li,Jinfeng Wu,Xiao Liu,Ruilong Wang,Jinhua Xu,Xiaohua Zhu

Frontiers in oncology 14:1471109 PubMed39582546

2024

Mechanism of luteolin against non-small-cell lung cancer: a study based on network pharmacology, molecular docking, molecular dynamics simulation, and experiments.

Applications

Unspecified application

Species

Unspecified reactive species

Jihang Zhang,Changling Li,Wenyi Li,Zhenpeng Shi,Zhenguo Liu,Junyu Zhou,Jing Tang,Zixuan Ren,Yun Qiao,Deshan Liu

Experimental and therapeutic medicine 28:320 PubMed38939173

2024

MIR193BHG inhibits the proliferation, migration and invasion of trophoblasts by upregulating p53.

Applications

Unspecified application

Species

Unspecified reactive species

Ping Wang,Yan Chen,Shuheng Yang,Junjun Gao,Zhan Zhang,Hong Li

American journal of translational research 16:690-699 PubMed38463590

2024

Complex phenotypic heterogeneity of combined hepatocellular-cholangiocarcinoma with a homogenous promoter mutation.

Applications

Unspecified application

Species

Unspecified reactive species

Sumie Ohni,Hiromi Yamaguchi,Yukari Hirotani,Yoko Nakanishi,Yutaka Midorikawa,Masahiko Sugitani,Tomohiro Nakayama,Makoto Makishima,Mariko Esumi

Journal of advanced research 67:71-92 PubMed38286301

2024

Simultaneous binding of quercetin and catechin to FOXO3 enhances IKKα transcription inhibition and suppression of oxidative stress-induced acute alcoholic liver injury in rats.

Applications

Unspecified application

Species

Unspecified reactive species

Hui Guan,Wenyuan Zhang,Hui Liu,Yang Jiang,Feng Li,Dan Wang,Yang Liu,Fatao He,Maoyu Wu,Geoffrey Ivan Neil Waterhouse,Dongxiao Sun-Waterhouse,Dapeng Li

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37:e23159 PubMed37650687

2023

Pan-cancer analysis: SPAG5 is an immunological and prognostic biomarker for multiple cancers.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaofeng Gao,Huitong Bu,Xuzheng Gao,Ying Wang,Long Wang,Zhenwang Zhang

Immunity, inflammation and disease 11:e973 PubMed37584301

2023

Hesperetin attenuates LPS-induced the inflammatory response and apoptosis of H9c2 by activating the AMPK/P53 signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Zan Xie,Chunxia Yang,Tingting Xu

Cellular & molecular biology letters 27:81 PubMed36180832

2022

Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62-Keap1-NRF2 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yanchun Li,Bing Xu,Xueying Ren,Luyang Wang,Yaqing Xu,Yefeng Zhao,Chen Yang,Chen Yuan,Huanjuan Li,Xiangmin Tong,Ying Wang,Jing Du

Experimental and therapeutic medicine 24:545 PubMed35978936

2022

Ginsenoside Rg1 ameliorates apoptosis, senescence and oxidative stress in ox-LDL-induced vascular endothelial cells via the AMPK/SIRT3/p53 signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Tian-Jiao Lyu,Zi-Xiu Zhang,Jun Chen,Zong-Jun Liu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com